Walleye Capital LLC Nektar Therapeutics Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $505,902 - $2.49 Million	790,472 Added 163.69%	1,273,379 $891,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $18,586 - $39,187	9,156 Added 1.93%	482,907 $1.09 Million
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $39,437 - $66,681	-12,973 Reduced 2.67%	473,751 $1.52 Million
Q2 2022 Aug 08, 2022	BUY	$3.17 - $6.17 $355,116 - $691,188	112,024 Added 29.9%	486,724 $1.85 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $1.56 Million - $5.14 Million	374,700 New	374,700 $2.02 Million
Q4 2021 Mar 03, 2022	SELL	$10.83 - $18.41 $141,602 - $240,710	-13,075 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $170,890 - $246,333	13,075 New	13,075 $235,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $357,811 - $550,114	-21,607 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $340,742 - $411,181	21,607 New	21,607 $367,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.